News | December 17, 2023
Biocon Biologics recognized as an Asia IP Elite for 2023
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The cognitively operated system is a mother patent invention, first launched in India
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Subscribe To Our Newsletter & Stay Updated
